Treatment with trastuzumab for 1 year after adjuvant chemotherapy in patients with HER2-positive early breast cancer: a 4-year follow-up of a randomised controlled trial. (Q53158182)
Jump to navigation
Jump to search
scientific article published on 25 February 2011
Language | Label | Description | Also known as |
---|---|---|---|
English | Treatment with trastuzumab for 1 year after adjuvant chemotherapy in patients with HER2-positive early breast cancer: a 4-year follow-up of a randomised controlled trial. |
scientific article published on 25 February 2011 |
Statements
Treatment with trastuzumab for 1 year after adjuvant chemotherapy in patients with HER2-positive early breast cancer: a 4-year follow-up of a randomised controlled trial (English)
Aron Goldhirsch
Anna Pluzanska
Richard D Gelber
Evandro Azambuja
Susanne Muehlbauer
Ian Smith
José Baselga
Christian Jackisch
David Cameron
Max Mano
José Luiz Pedrini
Andrea Veronesi
Cesar Mendiola
Eduard Vrdoljak
Michael J Eckart
Zhenzhou Shen
George Skiadopoulos
Marion Procter
Martine J Piccart-Gebhart
Richard Bell
Herceptin Adjuvant (HERA) Trial Study Team
25 February 2011